What a fantastic #EULAR2026 in London! Proud of the outstanding scientific contributions from our Division of Rheumatology @meduniwien.ac.at, from talks, posters and chairing to leadership in key sessions. Great visibility also for @squeezeproject.bsky.social and @autopix.bsky.social!

While in SQUEEZE we are researching Torque Teno Virus in #RA, a European team of nephrologists also led by @meduniwien.ac.at has recently shared first results on their investigator-intiated, multicentre, patient+central assessor-blinded, non-inferiority, randomized controlled phase II trial on #TTV.

While #EULAR2026 is slowly coming to an end, there's still more interesting contributions happening today. Join @simonsteiger.bsky.social and @nilssteinz.bsky.social at the poster view session starting at 10:15 am BST. 👇👇👇

Katy Antonopoulou shows a clear care gap: The rheumatologist may focus on RMD medication and disease activity. The gynaecologist/menopause specialist may focus on menopause symptoms. But the patient falls in the middle. That gap needs to close. #EULAR2026

Katy Antonopoulou’s recommendations to the clinical community are clear: Ask about menopause. Refer proactively. Reassure and inform patients. Work with patient associations. Advocate for multidisciplinary menopause-RMD clinics. #EULAR2026

Definitely one of our #EULAR2026 highlights: a very SQUEEZE-heavy line-up at the session "Please mind the gap: Approaches to implementing research into rheumatology practice" with @agneskocher2.bsky.social, @sabinadegeest.bsky.social, @estitxuloza.bsky.social & our patient research partner Ria. 💙👩👩‍🦱👩‍🦰

Full house at the poster tour of SQUEEZE expert Karolina Anderle from @meduniwien.ac.at on Day 3 of #EULAR2026! Karolina presented the determinants of methotrexate polyglutamate levels, the monitoring of which pose a great potential for personalised optimisation in MTX therapy.

Please help us by completing this survey on the availability, accessibility & affordability of #RA treatments across Europe. The results will help identify disparities in the treatment access across Europe & support future evidence-based recommendations for more equitable care. #EULAR2026

Time flies and it's already Day3 at #EULAR2026 where today at 9 am BST we will join a workshop led by @autopix.bsky.social on Stakeholder Involvement in EU-funded research. The workshop will be focusing on interactions with policymakers, regulators, and authorities. Very excited to meet everyone!

Therapy (DMARD) adherence is often poorly measured, that's why SQUEEZE developed a Care Model to improve adherence. This ehealth facilitated Model is being piloted in Switzerland with the goal to enhance routine rheumatological care. #EULAR2026 @agneskocher2.bsky.social @sabinadegeest.bsky.social

Our patient research partner Ria Brokken shares learnings of her work as a patient partner in the implementation of research into Rheumatology practice at #EULAR2026. We are lucky to have a full patient research panel supporting us in our clinical trials & the development of the SQUEEZE Care Model 💙

Why do promising healthcare innovations often fail to reach patients? 🤔 Today, SQUEEZE contributes to "Please mind the gap: Approaches to implementing research into Rheumatology Practice" starting 2:45 pm with talks on patient engagement & implementation science #EULAR2026 @agneskocher2.bsky.social

Did you notice the large crowd of people in the NPO area last night just before the networking dinner at #EULAR2026? There's heaps of passionate clinicians, scientists, HCP, & patients involved in a large number of EU consortia like SQUEEZE - come by at booth **O17** and learn more about our work!

Still wondering what SQUEEZE does? Learn more about our work in this @ec.europa.eu Horizon Magazine article: projects.research-and-innovation.ec.europa.eu/en/horizon-m... Intrigued? Come visit us at booth 📍O17 in the NPO section of #EULAR2026.

Harriet Morf, from the #SPIDeRR project had an spontaneous fast presentation during the HPR #EULAR26 fishbowl on digital health. DYK that 🇩🇪 already has an app in #axSpA? #Axia

At #EULAR2026, we recently presented the SQUEEZE experience at the PARE poster tour: a 3-year study developing, implementing and evaluating a stakeholder involvement strategy for a complex multinational RA research project, including patients, clinicians, researchers and other end users.

Shout out to our neighbours over at @mdr-ra-project.bsky.social - some of us might get confused these days at #EULAR2026 with all the EU consortia we are involved in. 🤪 We trust though that more collaboration will only lead to more learnings, better understanding & better lives for patients with #RA

🔔 Don't miss our first contribution at #EULAR2026! Estibaliz Loza Santamaria, @inmusc.bsky.social presents the SQUEEZE experience on stakeholder involvement in a multinational research project: 📍PARE Poster Tour 🕓 16:18 BST Because meaningful research is stronger when stakeholders help shape it.💙

💂‍♂️ London, we're ready! The SQUEEZE booth is set up and we're ready for #EULAR2026. Over the next few days we'll be sharing insights from our contributions and discussing how to maximise the impact of treatments for people living with #RheumatoidArthritis. 💙 Come say hello! 👋📍 O17 in the NPO area.

🌍 Few events bring together patients, researchers, clinicians, health professionals, & industry quite like #EULAR2026. We're now headed to the opening plenary to support the @eular.org president's Xenofon Baraliakos' inaugural speech. What's it gonna be this year? Bring popcorn & join us there! 😎🛴🎬🍿

SQUEEZE is coming to #EULAR2026! Getting ready to set up camp at Excel London for the next 4 days. 📍Come join us at booth **O17** & chat with our SQUEEZE ambassadors @caro-neum.bsky.social and Marta Sobrado from @meduniwien.ac.at and @qmul.bsky.social about our work on precision medicine in #RA.

🧳 It's #EULAR2026 week! Over the coming days, our team will share insights from SQUEEZE contributions, posters, workshops, and discussions in London - from patient involvement & implementation science to precision medicine & treatment optimisation in #RheumatoidArthritis. Join us for the ride! 👇

4th virtual @squeezeproject.bsky.social consortium meeting done. A moment to reflect on 3.5 years of work improving RA care and align on the road to Nov next year. Thanks to all of our partners!

💡 We don’t necessarily need more drugs for #RA - we need to use existing ones more effectively. Here's a recent article of the @ec.europa.eu's HORIZON magazine on SQUEEZE, feat. @danielaletaha.bsky.social & @agneskocher2.bsky.social projects.research-and-innovation.ec.europa.eu/en/horizon-m...

High disease activity is high disease activity is high disease activity? - Nope! Not all patients with rheumatoid arthritis are the same – even when they have exactly the same disease activity score! Full article: pubmed.ncbi.nlm.nih.gov/41839530/ Part of #SPIDERR and @squeezeproject.bsky.social

Congratulations to our scientific coordinator @meduniwien.ac.at for 30 years of University Rheumatology in Austria! Learn more about SQUEEZE via: squeeze-project.eu

New publication on therapeutic drug monitoring of biological drugs. Certolizumab plasma concentrations were influenced by dose & dose adjustments in a predictable manner shows newly published data by REMEDY and SQUEEZE: journals.lww.com/drug-monitor...

SQUEEZE tries to understand why #RheumatoidArthritis (RA) behaves so differently from one person to another & how this knowledge can help make treatment more personalised. This paper led by LUMC shows that WHERE #RA affects the body at diagnosis really matters: www.nature.com/articles/s41...

💊 Taking medication sounds simple - but for many people with RA, it isn’t. A scoping review protocol led by @agneskocher2.bsky.social et al. in 2024 focused on #adherence to DMARDs. This work reviews decades of research to better understand what influences adherence: osf.io/gb8dk/files/...

Learn more about the SQUEEZE project by exploring one of our first publications. 📰 rmdopen.bmj.com/content/10/4...

They have a #RMDream @squeezeproject.bsky.social #WAD2025

The #SQUEEZE care model is being presented at Oslo @squeezeproject.bsky.social meeting We will finally get to know the 3 components 😍: ePROM assessment-> segmentation-> tailored adherence intervention

When @squeezeproject.bsky.social people meet during the summer 🌞🕶️

At the Dresden Symposium on Autoantibodies 2025, Daniela Sieghart presented on biomarkers for RA treatment response, highlighting EU projects @squeezeproject.bsky.social & @autopix.bsky.social. Our division drives precision medicine forward, tailoring care through innovative biomarkers.

How to run #clinicaltrials in EU consortia? SQUEEZE expert Daniela Sieghart of @meduniwien.ac.at shares insights into the work of managing clinical studies during the Austrian Research Promotion Agency Coffee Chats on "Health in Action". 🎬 Watch the full talk via www.youtube.com/watch?v=3u6U...

Where's your SQUEEZE bag spending the summer? 😉☀️

How can we possibly fill the void after the end of #EULAR2025? Maybe by watching @eular.org's Kristina Chingov explain how to involve patient research partners in EU consortia during an Austrian Research Promotion Agency #FFG -led virtual coffee talk. ☕ Watch via 👉 www.youtube.com/watch?v=oyOC...

#EULAR2025 also offered the possibilty to come together for scientific project meetings. The @squeezeproject.bsky.social Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas

Check out my interview, masterfully led by Valentina Pucino after the plenary session of #EULAR2025 👇 www.youtube.com/watch?v=d6hi...

Full house and engaging discussions at Tjardo Marseveens (LUMC) talks today at #EULAR2025! Follow the SQUEEZE project on our LinkedIn channel or website to learn more about our latest results: LinkedIn: www.linkedin.com/company/sque... Web: squeeze-project.eu

We're back for Day 3 of #EULAR2025 with insights on the latest science done by the SQUEEZE consortium. Join us at booth #O3 in the glass walkway, near the Science Café. Our SciComm team is ready to introduce you to the work done in our project!🤗 @nicoleschmidtvie.bsky.social @caro-neum.bsky.social

Evaluation of the Torque Teno Virus as a potential immunologic marker in #RheumatoidArthritis presented by Daniel Mrak today. Interested in the potential of TTV as an "immunometer"? Follow @ttvguidetx.bsky.social on TTV-guided dosing of immunosuppressive drugs in kidney transplant recipients. #TTV

If you are at #EULAR2025, come and visit us at our stand in the Glass Walkway in the NPO Exhibition. You can win an anti-stress hippo and learn more about our HIPPOCRATES project including our HPOS study. 👉 hippocrates-imi.eu 👉 www.hpos.study

We had the great pleasure of welcoming a special guest at our booth yesterday. We consider ourselves very fortunate to have @danielaletaha.bsky.social & his glorious team at @meduniwien.ac.at leading our project. EU projects are highly complex & it's crucial to cruise with the right captain & crew!

At 3.15 pm today, SQUEEZE expert Daniela Di Giuseppe will present a poster during the poster tour comparing biological, targeted & conventional options of second DMARDs after #MTX in European RA cohorts. We are trying to understand which second #DMARD choice is the best for which group of patients.

Want to learn more about the contextual analysis done to develop the SQUEEZE Care Model? Come join us at booth #O3 in the NPO area / glass walkway and study the poster presented yesterday by the @inmusc.bsky.social team around @loreto-carmona.bsky.social. #EULAR2025

Full house and engaging discussions during @nilssteinz.bsky.social ‘s talk “Add-on vs. Replacement csDMARD Strategies Post-Methotrexate: A European analysis on csDMARD Treatment Choices" - exciting research funded by @squeezeproject.bsky.social & sister project SPIDERR led by Rachel Knevel at LUMC.

Day 2 of #EULAR2025 kicking off with a first highlight. Here's SQUEEZE expert @nilssteinz.bsky.social (LUMC) getting ready at the SQUEEZE booth for his talk "Add-on vs. Replacement csDMARD Strategies Post-Methotrexate: A European analysis on csDMARD Treatment Choices". 📍 Starting NOW in room A.2!

@meduniwien.ac.at is everywhere! 🤙🏼🥰

Day 1 at #EULAR2025 is coming to an end and we were happy and proud about the strong poster presence we had today by SQUEEZE experts from @inmusc.bsky.social and @meduniwien.ac.at i.e. on challenges in implementing evidence-based health interventions in the European Union.